Novel Biochemical Concepts behind Late Diabetic Complications.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 31, doi. 10.1177/155989771111019
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2011 AND VI 11 AND IP 11
Results: 18
1
2
Children at Risk — The Growing Prevalence of Type 2 Diabetes.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 30, doi. 10.1177/155989771111018
- By:
- Publication type:
- Article
3
Depression Has an Adverse Effect on Diabetes Treatment and Outcomes.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 29, doi. 10.1177/155989771111017
- By:
- Publication type:
- Article
4
Renal Disease and Diabetes.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 27, doi. 10.1177/155989771111016
- By:
- Publication type:
- Article
5
Diabetes and Cancer-Related Mechanisms.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 25, doi. 10.1177/155989771111015
- By:
- Publication type:
- Article
6
Intermittent Hypoxia — A Sleep Apnea Model.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 23, doi. 10.1177/155989771111014
- By:
- Publication type:
- Article
7
Pathogenesis: Obesity and Type 2 Diabetes.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 21, doi. 10.1177/155989771111013
- By:
- Publication type:
- Article
8
Liraglutide Reduces Insulin Dose without Affecting Glycemic Control in T1DM.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 17, doi. 10.1177/155989771111012
- By:
- Publication type:
- Article
9
Daily Insulin Dose at One Year Predicts Weight Gain in People with Type 2 Diabetes Newly Treated with Insulin.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 16, doi. 10.1177/155989771111011
- By:
- Publication type:
- Article
10
Triple Therapy with Liraglutide + Metformin + Insulin Detemir Improves Glycemic Control with No Weight Gain and Low Rates of Hypoglycemia.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 15, doi. 10.1177/155989771111010
- By:
- Publication type:
- Article
11
Combined Intensive BP and Glycemic Control Has No Benefit in Reducing CV Risk in Patients with T2DM.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 15, doi. 10.1177/155989771111009
- By:
- Publication type:
- Article
12
Efficacy of a Bihormonal Closed-Loop System to Control Postprandial and Post Exercise Glucose Excursions.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 14, doi. 10.1177/155989771111008
- By:
- Publication type:
- Article
13
Efficacy and Safety of Once-Weekly Exenatide versus Daily Liraglutide in Subjects with T2DM (DURATION-6).
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 13, doi. 10.1177/155989771111007
- By:
- Publication type:
- Article
14
EndoBarrier® Rapidly Improves Diabetes Parameters.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 11, doi. 10.1177/155989771111005
- By:
- Publication type:
- Article
15
No Increased CV Events with DPP-4 Inhibitors.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 11, doi. 10.1177/155989771111004
- By:
- Publication type:
- Article
16
The Metabolic Brain.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 8, doi. 10.1177/155989771111002
- By:
- Publication type:
- Article
17
TAK-875 Reduces HbA1C in Patients with T2DM.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 10, doi. 10.1177/155989771111003
- By:
- Publication type:
- Article
18
Cardioprotective Therapies and Diabetes Risk: An Overview.
- Published in:
- MD Conference Express, 2011, v. 11, n. 11, p. 6, doi. 10.1177/155989771111001
- By:
- Publication type:
- Article